SN BioScience
PrivateLast Round
Growth Equity
Apr 7, 2026
Est. Valuation
$15.16M
Total Funding Raised
$27.01M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
SN BioScience is a biotechnology company that develops innovative drug delivery systems, particularly nanomedicine and nanoparticle-based therapies for oncology and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SN BioScience Comparables
Compare SN BioScience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OncoNano Medicine | 79% | |
| RS Research | 74% | |
| Samyang Holdings | 71% |
SN BioScience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Apr 7, 2026 | ||||
| Series B | Jul 1, 2020 | ||||
| Series A | Jan 21, 2019 |
SN BioScience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Smilegate Investment | Series A, Series B |
| SL Investment | Series B |
| DAYLI Partners | Growth Equity |
| Comes Investment | Series B |
| Now IB Capital | Growth Equity |
| JL Partners | Series B |
| Wonik Investment Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 236% MoM, reaching 3K.
- Apr 27, 2026
Grew 100% QoQ from 3 to 6 employees.
SN BioScience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SN BioScience's valuation, stock price, and market status.
Is SN BioScience a public or private company?
SN BioScience is a private company.
What is the current stock price of SN BioScience?
SN BioScience is a private company with no public stock price. No recent secondary market data is available.
How much is SN BioScience worth (valuation)?
SN BioScience's valuation is estimated at $15.2M based on funding round data.
Can I buy SN BioScience stock?
SN BioScience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SN BioScience's last funding round?
SN BioScience's most recent funding round was Growth Equity on January 21, 2019.
Who are the main investors in SN BioScience?
Key investors in SN BioScience include Smilegate Investment, SL Investment, DAYLI Partners, Comes Investment, Now IB Capital.
Will SN BioScience IPO soon?
No public IPO plans have been announced for SN BioScience.
How can I track SN BioScience secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SN BioScience's secondary market activity and sign up for updates.